Price (delayed)
$0.4599
Market cap
$11.42M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.56
Enterprise value
$10.91M
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical and industrial applications. Founded in 2005, Ekso ...
Highlights
EKSO's EPS is up by 49% year-on-year and by 14% since the previous quarter
The net income has grown by 25% YoY
EKSO's quick ratio is down by 10% QoQ but it is up by 3.4% YoY
Ekso Bionics Holdings's equity has decreased by 15% QoQ
Key stats
What are the main financial stats of EKSO
MarketValuationsEarnings
Shares outstanding
24.82M
Market cap
$11.42M
Enterprise value
$10.91M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.8
Price to sales (P/S)
0.52
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.61
Revenue
$17.93M
Gross profit
$9.51M
Operating income
-$10.46M
Net income
-$11.33M
EBIT
-$11.06M
EBITDA
-$9.45M
Free cash flow
-$9.88M
Per shareBalance sheetLiquidity
EPS
-$0.56
EPS diluted
-$0.56
Free cash flow per share
-$0.49
Book value per share
$0.58
Revenue per share
$0.89
TBVPS
$1.07
Total assets
$26.65M
Total liabilities
$13.95M
Debt
$5.98M
Equity
$12.71M
Working capital
$11.31M
Debt to equity
0.47
Current ratio
2.5
Quick ratio
1.82
Net debt/EBITDA
0.05
MarginsEfficiencyDividend
EBITDA margin
-52.7%
Gross margin
53.1%
Net margin
-63.2%
Operating margin
-58.4%
Return on assets
-40.5%
Return on equity
-84.4%
Return on invested capital
-76.8%
Return on capital employed
-57.9%
Return on sales
-61.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EKSO stock price
How has the Ekso Bionics Holdings stock price performed over time
Intraday
13.67%
1 week
14.15%
1 month
-19.88%
1 year
-67.38%
YTD
-24.61%
QTD
-24.61%
Financial performance
How have Ekso Bionics Holdings's revenue and profit performed over time
Revenue
$17.93M
Gross profit
$9.51M
Operating income
-$10.46M
Net income
-$11.33M
Gross margin
53.1%
Net margin
-63.2%
EKSO financials
EKSO's operating income is up by 31% year-on-year and by 10% since the previous quarter
EKSO's operating margin is up by 29% YoY and by 12% QoQ
The net income has grown by 25% YoY
The net margin is up by 24% YoY
Growth
What is Ekso Bionics Holdings's growth rate over time
EKSO growth chart
Valuation
What is Ekso Bionics Holdings stock price valuation
P/E
N/A
P/B
0.8
P/S
0.52
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.61
Price to earnings (P/E)
EKSO's EPS is up by 49% year-on-year and by 14% since the previous quarter
Price to book (P/B)
EKSO's P/B is 67% below its 5-year quarterly average of 2.1 and 53% below its last 4 quarters average of 1.5
Ekso Bionics Holdings's equity has decreased by 15% QoQ
Price to sales (P/S)
The stock's price to sales (P/S) is 84% less than its 5-year quarterly average of 2.8 and 58% less than its last 4 quarters average of 1.1
Efficiency
How efficient is Ekso Bionics Holdings business performance
The ROIC has grown by 29% YoY but it has contracted by 2.7% from the previous quarter
EKSO's return on sales is up by 24% year-on-year
The ROA has grown by 13% YoY but it has contracted by 3.8% from the previous quarter
The ROE has grown by 7% YoY
Dividends
What is EKSO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EKSO.
Financial health
How did Ekso Bionics Holdings financials performed over time
Assets vs liabilities
Ekso Bionics Holdings's total assets is 91% more than its total liabilities
EKSO's total liabilities is down by 15% YoY and by 2.7% QoQ
The current ratio has declined by 11% since the previous quarter
Debt vs equity
The debt is 53% lower than the equity
The debt to equity has declined by 18% year-on-year but it has grown by 9% since the previous quarter
The debt is down by 17% YoY and by 6% QoQ
Balance sheet
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from 
and Sharadar.